← Leaderboards
Wojciech Zareba
University Of Rochester
$21,736,071
Attributed
$31,199,672
Total exposure
11
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2005–24$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$31,199,672 · 11
By mechanism
R01$21,426,397 · 6
U01$8,989,552 · 3
R34$712,732 · 1
M01$70,991 · 1
Top collaborators
- Frank I Marcus5 shared
- Luisa Mestroni5 shared
- Jeffrey E Saffitz5 shared
- Jeffrey A Towbin5 shared
- Linwei Wang5 shared
- Robert S Kass2 shared
Most similar at University Of Rochester
Same institution · by research overlap
- Valentina Kutyifa Valentina Kutyifa Valentina Kutyifa$4,790,361
- Arthur J. Moss$13,356,209
- John D. Lueck$4,627,632
- Roderick Tung$1,601,091
- Eric M Small$9,887,143
Others in their field
Top investigators on “Heart Failure”
- Judith S Hochman · New York University School Of Medicine$120,321,606
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$51,947,333
- Lisa P Jacobson · Johns Hopkins University$45,397,923
- Walter N Kernan · Yale University$42,197,025
- Dalane W Kitzman · Wake Forest University$40,701,149
- David Couper · Univ Of North Carolina Chapel Hill$37,959,091
Research focus
Heart FailureLeadCardiacEventMyocardiumVentricularClinical TrialsCardiomyopathiesCessation Of LifeMyocardialLeftBaseArrhythmiaElectrocardiogramPharmaceutical PreparationsVentricular ArrhythmiaQuality Of LifeEnrollmentCellsInterestImplantable DefibrillatorsNational Heart, Lung, And Blood InstituteAdverse EventCohort
Grant awards (39)
Inconspicuous Daily Monitoring to Reduce Heart Failure Hospitalizations$596,810
R01 · FY2024 · NR
Inconspicuous Daily Monitoring to Reduce Heart Failure Hospitalizations$599,371
R01 · FY2023 · NR
Inconspicuous Daily Monitoring to Reduce Heart Failure Hospitalizations$599,038
R01 · FY2022 · NR
Clinical, Electrocardiographic, and Cardiac Magnetic Resonance Imaging Risk Factors Associated with Ventricular Tachyarrhythmias in Nonischemic Cardiomyopathy$743,820
R01 · FY2021 · HL · contact PI
Inconspicuous Daily Monitoring to Reduce Heart Failure Hospitalizations$410,482
R01 · FY2021 · NR
Clinical, Electrocardiographic, and Cardiac Magnetic Resonance Imaging Risk Factors Associated with Ventricular Tachyarrhythmias in Nonischemic Cardiomyopathy$755,756
R01 · FY2020 · HL · contact PI
Inconspicuous Daily Monitoring to Reduce Heart Failure Hospitalizations$597,754
R01 · FY2020 · NR
Clinical, Electrocardiographic, and Cardiac Magnetic Resonance Imaging Risk Factors Associated with Ventricular Tachyarrhythmias in Nonischemic Cardiomyopathy$763,304
R01 · FY2019 · HL · contact PI
Pilot Randomized Trial with Flecainide in ARVC Patients$349,844
R34 · FY2019 · HL · contact PI
Clinical, Electrocardiographic, and Cardiac Magnetic Resonance Imaging Risk Factors Associated with Ventricular Tachyarrhythmias in Nonischemic Cardiomyopathy$780,853
R01 · FY2018 · HL · contact PI
Clinical and Basic Science Studies in Long QT Syndrome Type 3$733,092
R01 · FY2018 · HL · contact PI
Pilot Randomized Trial with Flecainide in ARVC Patients$362,888
R34 · FY2018 · HL · contact PI
Clinical and Basic Science Studies in Long QT Syndrome Type 3$742,812
R01 · FY2017 · HL · contact PI
Genetics, Mechanisms and Clinical Phenotypes of Arrhythmogenic Cardiomyopathy$2,356,223
R01 · FY2016 · HL
Genetics, Mechanisms and Clinical Phenotypes of Arrhythmogenic Cardiomyopathy$2,350,202
R01 · FY2015 · HL
Late Sodium Current Blockade in High-Risk ICD Patients - CCC - Lead Application$1,046,501
U01 · FY2015 · HL · contact PI
Late Sodium Current Blockade in High-Risk ICD Patients - DCC$365,940
U01 · FY2015 · HL · contact PI
Genetics, Mechanisms and Clinical Phenotypes of Arrhythmogenic Cardiomyopathy$2,212,258
R01 · FY2014 · HL
Late Sodium Current Blockade in High-Risk ICD Patients - CCC - Lead Application$1,496,252
U01 · FY2014 · HL · contact PI
Genetics, Mechanisms and Clinical Phenotypes of Arrhythmogenic Cardiomyopathy$79,695
R01 · FY2014 · HL
Genetics, Mechanisms and Clinical Phenotypes of Arrhythmogenic Cardiomyopathy$2,156,524
R01 · FY2013 · HL
Late Sodium Current Blockade in High-Risk ICD Patients - CCC - Lead Application$407,107
U01 · FY2013 · HL · contact PI
Late Sodium Current Blockade in High-Risk ICD Patients - CCC - Lead Application$1,535,183
U01 · FY2012 · HL · contact PI
Late Sodium Current Blockade in High-Risk ICD Patients - CCC - Lead Application$1,449,353
U01 · FY2010 · HL · contact PI
Risk Stratification in MADIT II Type Patients$619,176
R01 · FY2008 · HL · contact PI
Risk Stratification in MADIT II Type Patients$639,881
R01 · FY2007 · HL · contact PI
Risk Stratification in MADIT II Type Patients$744,156
R01 · FY2006 · HL · contact PI
Risk Stratification in MADIT II Type Patients$680,027
R01 · FY2005 · HL
Multidisciplinary Study of Right Ventricular Dysplasia$310,627
U01 · FY2005 · HL
STUDY OF VENTRICULAR REPOLARIZATION IN LONG QT SYNDROME$14,045
M01 · FY2005 · RR
Study of Ventricular Repolarization in Long QT Syndrome$593,137
R01 · FY2004 · HL
Multidisciplinary Study of Right Ventricular Dysplasia$531,535
U01 · FY2004 · HL
Study of Ventricular Repolarization in Long QT Syndrome$56,946
M01 · FY2004 · RR
Study of Ventricular Repolarization in Long QT Syndrome$572,860
R01 · FY2003 · HL
Multidisciplinary Study of Right Ventricular Dysplasia$511,082
U01 · FY2003 · HL
Multidisciplinary Study of Right Ventricular Dysplasia$601,748
U01 · FY2002 · HL
Study of Ventricular Repolarization in Long QT Syndrome$563,762
R01 · FY2002 · HL
Multidisciplinary Study of Right Ventricular Dysplasia$734,224
U01 · FY2001 · HL
Study of Ventricular Repolarization in Long QT Syndrome$535,404
R01 · FY2001 · HL